Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
1,2,4-Thiadiazol-5-amine--hydrogen chloride (1/1) → 4-(2-Oxo-4-(2,2,2-trifluoroacetyl)piperazin-1-yl)-n-(1,2,4-thiadiazol-5-yl)benzenesulfonamide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 1,2,4-Thiadiazol-5-amine--hydrogen chloride (1/1) | HCID 22014543 | — |
| 반응물 | HCID 59465974 | HCID 59465974 | — |
| 용매 | Pyridine | HCID 1049 | — |
| 생성물 | 4-(2-Oxo-4-(2,2,2-trifluoroacetyl)piperazin-1-yl)-n-(1,2,4-thiadiazol-5-yl)benzenesulfonamide | HCID 59466402 | 48% |
반응 단계
Synthesized according to general procedure 12, method A. The reaction was set up with 1,2,4-Thiadiazol-5-ylamine hydrochloride (0.56 g, 4.0 mmol), anhydrous pyridine (3.5 mL), and 4-(2-oxo-4-(2,2,2-trifluoroacetyl)piperazin-1-yl)benzene-1-sulfonyl chloride (1.5 g, 4.0 mmol). The dark oil was purified via silica gel chromatography using 5% MeOH in CH2Cl2 followed by a second purification on silica gel using 80% EtOAc in hexanes to obtain the desired sulfonamide as a white solid (0.73 g, 1.92 mmol, 48% yield). LC/MS (10%-99% CH3CN (0.035% TFA)/H2O (0.05% TFA)), m/z: M+1 obs=436.1; tR=2.27 min.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07799822B2 |
| 출처 데이터셋 | uspto-grants-2010_09 |
| ORD ID | ord-561ccc82fd7a4119a0f72ef7ce4e94bf |
| 출처 메모 | uspto-grants-2010_09 |